MarketScreener Strategies Merck KGaA

Stocks

Market Closed - Xetra Other stock markets 19:38:29 10/07/2026 +04			5-day change	1st Jan Change
139.70 ^EUR	+0.07%		-4.09%	+13.95%

07-09	Merck Receives FDA Breakthrough Therapy Designation For Enpatoran In Lupus Patients With Active Skin Manifestations	CI
07-08	Merck KGaA's Lupus Drug Gets US FDA Breakthrough Therapy Designation	MT

	Merck KGaA: From 19th-century cocaine to tomorrow's AI chips	May 19, 2026 at 01:00 pm
	Merck: An upgrade in Q1 signals high confidence	May 13, 2026 at 03:54 pm
	Merck: Pharma business’s reinvigoration remains key for re-rating	April 16, 2026 at 10:43 am
	Merck: Q4 miss and slightly weak 2026 guidance	March 05, 2026 at 07:31 pm
	Merck target raised after analyst change	December 19, 2025 at 07:45 pm
	Merck delivers Q3 earnings beat and maintains 2025 outlook	November 13, 2025 at 06:06 pm
	Merck KGaA : A European big pharma with positive momentum	January 20, 2023 at 02:51 pm